[Federal Register Volume 87, Number 166 (Monday, August 29, 2022)]
[Proposed Rules]
[Pages 52712-52713]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18558]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

42 CFR Part 493

[CMS-3326-N]
RIN 0938-AT47


Clinical Laboratory Improvement Amendments of 1988 (CLIA) Fees; 
Histocompatibility, Personnel, and Alternative Sanctions for 
Certificate of Waiver Laboratories; Extension of Comment Period

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS; Centers 
for Disease Control and Prevention (CDC), HHS.

ACTION: Proposed rule; extension of comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Medicare & Medicaid Services (CMS) and the 
Centers for Disease Control and Prevention (CDC) within the Department 
of Health and Human Services (HHS) announce the extension of the 
comment period for the proposed rule entitled ``Clinical Laboratory 
Improvement Amendments of 1988 (CLIA) Fees; Histocompatibility, 
Personnel, and Alternative Sanctions for Certificate of Waiver 
Laboratories.''

DATES: The comment period for the proposed rule published July 26, 2022 
(87 FR 44896), is extended through September 26, 2022.

ADDRESSES: In commenting, please refer to file code CMS-3326-P.
    Comments, including mass comment submissions, must be submitted in 
one of the following three ways (please choose only one of the ways 
listed):
    1. Electronically. You may submit electronic comments on this 
regulation to https://www.regulations.gov. Follow the ``Submit a 
comment'' instructions.
    2. By regular mail. You may mail written comments to the following 
address ONLY: Centers for Medicare & Medicaid Services, Department of 
Health and Human Services, Attention: CMS-3326-P, P.O. Box 8016, 
Baltimore, MD 21244-8016.
    Please allow sufficient time for mailed comments to be received 
before the close of the comment period.
    3. By express or overnight mail. You may send written comments to 
the following address ONLY: Centers for Medicare & Medicaid Services, 
Department of Health and Human Services, Attention: CMS-3326-P, Mail 
Stop C4-26-05, 7500 Security Boulevard, Baltimore, MD 21244-1850.

FOR FURTHER INFORMATION CONTACT: Sarah Bennett, CMS, (410) 786-3531, 
Serafina Brea, CMS, (410) 786-3531, or Heather Stang, CDC, 404-498-
2769.

SUPPLEMENTARY INFORMATION: In the ``Clinical Laboratory Improvement 
Amendments of 1988 (CLIA) Fees; Histocompatibility, Personnel, and 
Alternative Sanctions for Certificate of Waiver Laboratories'' proposed 
rule that appeared in the July 26, 2022 Federal Register (87 FR 44896), 
we solicited public comments on proposed changes to CLIA fees, 
histocompatibility and personnel requirements, and alternative 
sanctions for Certificate of Waiver laboratories.
    In response to requests we received from several laboratory 
professional organizations, we are extending the comment period an 
additional 30 days. This extension will maximize the opportunity for 
the public to provide

[[Page 52713]]

meaningful input to CMS and CDC) for an additional 30 days.

    Dated: August 24, 2022.
Xavier Becerra,
Secretary, Department of Health and Human Services.
[FR Doc. 2022-18558 Filed 8-24-22; 4:15 pm]
BILLING CODE 4120-01-P